Currently, the major hypotheses for the development of depression include the monoamine reduction hypothesis, overactivation of the hypothalamus-pituitary-adrenal (HPA) axis, and the decrease in brain-derived neurotrophic factor (BDNF) levels (Sonali et al., 2022). The gene discussed is BDNF; the disease is depressive symptom measurement.